0001104659-22-071965.txt : 20220616
0001104659-22-071965.hdr.sgml : 20220616
20220616170358
ACCESSION NUMBER: 0001104659-22-071965
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220614
FILED AS OF DATE: 20220616
DATE AS OF CHANGE: 20220616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bellemin Jean-Marc
CENTRAL INDEX KEY: 0001754253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36860
FILM NUMBER: 221021358
MAIL ADDRESS:
STREET 1: C/O GRITSTONE ONCOLOGY, INC.
STREET 2: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IOVANCE BIOTHERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001425205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 753254381
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: 4TH FLOOR
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 6502607120
MAIL ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: 4TH FLOOR
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
FORMER COMPANY:
FORMER CONFORMED NAME: Lion Biotechnologies, Inc.
DATE OF NAME CHANGE: 20131015
FORMER COMPANY:
FORMER CONFORMED NAME: Genesis Biopharma, Inc
DATE OF NAME CHANGE: 20100319
FORMER COMPANY:
FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP
DATE OF NAME CHANGE: 20080128
4
1
tm2218629-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-14
0
0001425205
IOVANCE BIOTHERAPEUTICS, INC.
IOVA
0001754253
Bellemin Jean-Marc
C/O IOVANCE BIOTHERAPEUTICS, INC.
825 INDUSTRIAL ROAD, 4TH FLOOR
SAN CARLOS
CA
94070
0
1
0
0
Chief Financial Officer
Common Stock
2022-06-14
4
M
0
18850
0
A
18850
D
Common Stock
2022-06-14
4
F
0
9346
7.73
D
9504
D
Restricted Stock Units
2022-06-14
4
A
0
18850
0.00
A
Common stock
18850
18850
D
This is the first vesting of the restricted stock units issued on June 14, 2021.
Represents common stock owned by the Reporting Person, excluding common stock purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan.
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities.
Represents common stock remaining after deducting the common stock withheld for taxes.
Represents restricted stock units remaining after deducting the vested shares of common stock and common stock withheld for taxes as set forth in Table I above.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date.
/s/ Jean Marc-Bellemin
2022-06-16